Cargando…

EE184 Assessing the Cost-Effectiveness of the Novavax COVID-19 Vaccine as a Potential Booster Vaccine Option for Adults in the United States

Detalles Bibliográficos
Autores principales:	Paret, K, Beyhaghi, H, Herring, W, Rousculp, M, Toback, S, Mauskopf, J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747425/ http://dx.doi.org/10.1016/j.jval.2022.09.434

Ejemplares similares

Safety and Adverse Events Related to Inactivated COVID-19 Vaccines and Novavax;a Systematic Review
por: Dadras, Omid, et al.
Publicado: (2022)

Interim Recommendation of the Advisory Committee on Immunization Practices for Use of the Novavax COVID-19 Vaccine in Persons Aged ≥18 years — United States, July 2022
por: Twentyman, Evelyn, et al.
Publicado: (2022)

EE329 The Value-Based Price for a Bivalent COVID-19 Booster Vaccine in the United Kingdom
por: Kohli, M., et al.
Publicado: (2023)

Efficacy of mRNA-1273 and Novavax ancestral or BA.1 spike booster vaccines against SARS-CoV-2 BA.5 infection in non-human primates
por: Routhu, Nanda Kishore, et al.
Publicado: (2023)

A Case Report for Acute Myopericarditis After NVX-CoV2373 (Novavax(®)) COVID-19 Vaccination
por: Kim, Hyung Yoon, et al.
Publicado: (2022)

Notes from the Field: Safety Monitoring of Novavax COVID-19 Vaccine Among Persons Aged ≥12 Years — United States, July 13, 2022–March 13, 2023
por: Romanson, Brittney, et al.
Publicado: (2023)

Novavax NVX-COV2373 triggers neutralization of Omicron sub-lineages
por: Bhiman, Jinal N., et al.
Publicado: (2023)

FCC-ee Pre-Booster Accelerators
por: Ogur, S, et al.
Publicado: (2017)

Cost-effectiveness analysis of BNT162b2 COVID-19 booster vaccination in the United States
por: Li, Rui, et al.
Publicado: (2022)

COVID-19 Booster Dose Vaccination Coverage and Factors Associated with Booster Vaccination among Adults, United States, March 2022
por: Lu, Peng-jun, et al.
Publicado: (2023)

Status of the FCC-ee Top-Up Booster Synchrotron
por: Härer, Bastian, et al.
Publicado: (2018)

COVID-19 Bivalent Booster Vaccination Coverage and Intent to Receive Booster Vaccination Among Adolescents and Adults — United States, November–December 2022
por: Lu, Peng-jun, et al.
Publicado: (2023)

Myopericarditis Associated with the Novavax COVID-19 Vaccine (NVX-CoV2373): A Retrospective Analysis of Individual Case Safety Reports from VigiBase
por: Macías Saint-Gerons, Diego, et al.
Publicado: (2023)

Challenges and Status of the Rapid Cycling Top-Up Booster for FCC-ee
por: Härer, Bastian, et al.
Publicado: (2017)

Optics design and correction challenges for the high energy booster of FCC-ee
por: Chance, Antoine, et al.
Publicado: (2023)

Study of collective effects in the CERN FCC-ee top-up booster
por: Quartullo, D., et al.
Publicado: (2020)

Design Studies Towards the FCC-ee Booster Ring Injection and Extraction
por: Howling, Emily Rose
Publicado: (2022)

Editorial: First Approval of the Protein-Based Adjuvanted Nuvaxovid (NVX-CoV2373) Novavax Vaccine for SARS-CoV-2 Could Increase Vaccine Uptake and Provide Immune Protection from Viral Variants
por: Parums, Dinah V.
Publicado: (2022)

Cost-effectiveness of Human Papillomavirus Vaccination in the United States
por: Chesson, Harrell W., et al.
Publicado: (2008)

Cost-Effectiveness of Pneumococcal Vaccines for Adults in the United States
por: Chen, Jieling, et al.
Publicado: (2014)

EE71 Cost-Effectiveness of COVID-19 Vaccination in Colombia: A Micro-Simulation Modelling Analysis
por: Castañeda-Orjuela, C, et al.
Publicado: (2022)

EE540 Cost-Effectiveness of Vaccines Targeting Infectious Diseases - Has COVID-19 Changed the Landscape?
por: Pitman, R, et al.
Publicado: (2022)

EE19 Cost-Effectiveness Analysis of Nonpharmaceutical Interventions Combined with Inactivated Vaccination and Oral Medicine in China
por: Fu, F., et al.
Publicado: (2023)

Booster Vaccination: The Role of Reduced Antigen Content Vaccines as a Preschool Booster
por: Gabutti, Giovanni, et al.
Publicado: (2014)

Cost effectiveness of fractional doses of COVID-19 vaccine boosters in India
por: Du, Zhanwei, et al.
Publicado: (2023)

Tapering Options and Emittance Fine Tuning for the FCC-ee Collider
por: Härer, Bastian, et al.
Publicado: (2016)

EE564 Study on the Value Pricing of COVID-19 Vaccine in China Based on the Evidence of Cost-Effectiveness Analysis
por: Fu, Y., et al.
Publicado: (2023)

1097 Cost-Effectiveness of Pneumococcal Vaccines for Adults in the United States
por: Yang, H. Keri, et al.
Publicado: (2014)

Willingness to obtain COVID-19 vaccination in adults with multiple sclerosis in the United States
por: Ehde, Dawn M., et al.
Publicado: (2021)

Lattice Design and Dynamic Aperture Studies for the FCC-ee Top-Up Booster Synchrotron
por: Haerer, Bastian, et al.
Publicado: (2021)

COVID-19 booster vaccination coverage among adults, children and adolescents and reasons for non-receipt, United States
por: Nguyen, Kimberly H., et al.
Publicado: (2023)

Are COVID-19 Vaccine Boosters Needed? The Science behind Boosters
por: Burckhardt, Rachel M., et al.
Publicado: (2022)

Booster vaccines for COVID-19 vaccine breakthrough cases?
por: Nixon, Douglas F, et al.
Publicado: (2022)

HOM damping options for the Z-pole operating scenario of FCC-ee
por: Gorgi Zadeh, Shahnam, et al.
Publicado: (2019)

The Potential Cost-Effectiveness of Pre-Exposure Prophylaxis Combined with HIV Vaccines in the United States
por: Adamson, Blythe J. S., et al.
Publicado: (2017)

Vaccine and Psychological Booster: Factors Associated With Older Adults’ Compliance to the Booster COVID-19 Vaccine in Israel
por: Ben-David, Boaz M., et al.
Publicado: (2022)

Internal decay of the (10$^{-}$) intruder state in $^{184}$TI
por: Van Beveren, C, et al.
Publicado: (2015)

Comparing Cost-Effectiveness Results for a Vaccine Across Different Countries Worldwide: What Can We Learn?
por: Standaert, Baudouin, et al.
Publicado: (2014)

The Impact of Social Determinants of Health on Meningococcal Vaccination Awareness, Delivery, and Coverage in Adolescents and Young Adults in the United States: A Systematic Review
por: Masaquel, Catherine, et al.
Publicado: (2023)

With established safe and effective use, protein vaccines offer another choice against COVID-19
por: Marchese, Anthony M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_04j16pgai9kpokp7b870itmcnj